You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 14, 2026

Claims for Patent: 12,226,406

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 12,226,406

Title:	Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea
Abstract:	Provided herein are low impurity compositions comprising a compound represented by Formula (I): which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRα kinases, and oncogenic forms thereof.
Inventor(s):	Michael D. Kaufman, Scott Bone, Corey Bloom, Fred Jordan
Assignee:	Deciphera Pharmaceuticals LLC
Application Number:	US18/795,711
Patent Claims:	1. A pharmaceutical composition comprising: a solid dispersion comprising: a compound represented by Formula (I) or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable polymer, wherein the pharmaceutically acceptable polymer is hydroxypropylmethyl cellulose acetate succinate; and one or more anilinic substances, wherein the one or more anilinic substances, is present in an amount equal to or less than about 10% by weight based on the weight of the compound of Formula (I) present in the composition, and wherein water is present in the composition in an amount of no more than about 6% by weight based on the total weight of the pharmaceutical composition. 2. The pharmaceutical composition of claim 1, wherein the one or more anilinic substances is present in an amount equal to or less than about 5% by weight based on the weight of the compound of Formula (I) present in the composition. 3. The pharmaceutical composition of claim 1, wherein each of the one or more anilinic substances is present in an amount equal to or less than about 3% by weight based on the weight of the compound of Formula (I) present in the composition. 4. The pharmaceutical composition of claim 1, wherein the one or more anilinic substances is present in an amount equal to or less than about 1% by weight based on the weight of the compound of Formula (I) present in the composition. 5. The pharmaceutical composition of claim 1, wherein the one or more anilinic substances is present in an amount equal to or less than about 0.5% by weight based on the weight of the compound of Formula (I) present in the composition. 6. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 5% by weight based on the total weight of the pharmaceutical composition. 7. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 4% by weight based on the total weight of the pharmaceutical composition. 8. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 3% by weight to about 4% by weight based on the total weight of the pharmaceutical composition. 9. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 3.5% by weight based on the total weight of the pharmaceutical composition. 10. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 3.4% by weight based on the total weight of the pharmaceutical composition. 11. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 3% by weight based on the total weight of the pharmaceutical composition. 12. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 2% by weight based on the total weight of the pharmaceutical composition. 13. The pharmaceutical composition of claim 1, wherein water is present in the composition in an amount of no more than about 1% by weight based on the total weight of the pharmaceutical composition.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.